Scarica l'app Stockscreener
214.06
1.09%
2.30
Dopo l'orario di chiusura:
214.06
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DHR Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Danaher Corp Borsa (DHR) Ultime notizie
Danaher Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Danaher stock after-hours at EUR 191.10: minus 2.35 percent - AD HOC NEWS
Danaher Corp Stock (DHR) Moved Down by 3.29% on Oct 1: What Investors Need To Know - TradingKey
Continuous Bioprocessing Technologies Market - GlobeNewswire Inc.
Danaher names Julie Sawyer Montgomery as president and CEO - Investing.com
Goldman Sachs raises target for Danaher stock to USD 250.00 - AD HOC NEWS
Guggenheim Raises Price Target on Danaher to $250 From $200, Keeps Buy Rating - marketscreener.com
What You Need to Know Ahead of Danaher’s Earnings Release - Yahoo Finance
Julie Sawyer Montgomery Assumes Role as Danaher President and Chief Executive Officer - Yahoo Finance
Danaher stock pre-market at EUR 196.30: plus 0.31 percent - AD HOC NEWS
Danaher Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
A voluntary NYSE withdrawal covers Danaher (NYSE: DHR) 2.100% senior notes due 2026. - Stock Titan
DHR's Growth Backed by Strong Biotechnology Unit: Can It Maintain the Pace? - Yahoo Finance
Masimo Wins Two OCTANE High Tech AwardsCompany Recognized for 'Deal of the Year' and 'Best Technology Leadership Team' - PR Newswire
Danaher stock trades at EUR 198.48 ahead of October 21 results - AD HOC NEWS
Danaher stock after-hours at EUR 198.88: minus 0.10 percent versus the Lang & Schwarz prior close - AD HOC NEWS
Leica Biosystems Completes Acquisition of StatLab to Bolster Delivery of More Precise, Timely Diagnostics for Cancer Patients - marketscreener.com
Leica Biosystems Acquires StatLab From Linden Capital And Audax Private Equity - Pulse 2.0
Danaher stock reports USD 6.26 billion Q2 revenue ahead of earnings - AD HOC NEWS
Danaher stock at USD 224.49 on September 25, 2026 - AD HOC NEWS
Gilead vs. Danaher: Which Healthcare Growth Story is More Convincing? - Yahoo Finance
Danaher Corp Agencies, 2024 - OpenSecrets
Global Therapeutic Drug Monitoring Consumables Market Forecast, 2026-2032 - GlobeNewswire Inc.
Danaher Corp Lobbyists, 2024 - OpenSecrets
Danaher Corp Lobbyists, 2022 - OpenSecrets
Danaher Corp. stock slips before the bell - AD HOC NEWS
What Does Veralto's (NYSE:VLTO) Dividend and Climate Validation Signal? - Kalkine Media
Danaher Corporation stock sets October earnings date - AD HOC NEWS
DHR|Danaher Corp|Price:227.330|Chg%:+2.840 - TradingKey
Danaher stock heads into the open after a 2.43 percent gain - AD HOC NEWS
Danaher stock ends the day 2.43 percent higher at USD 221.09 - AD HOC NEWS
Danaher (DHR) Stock Looks Reasonable On Label Free Detection Growth - Yahoo Finance
Danaher Corp. stock holds near USD 200 before October results - AD HOC NEWS
Danaher (DHR) Institutional Ownership 2026 $DHR - MarketBeat
Danaher stock rises 0.16 percent ahead of the open - AD HOC NEWS
Automated Microscopy Market Advances as AI-Powered Image Analysis Transforms Digital Pathology and Semiconductor Inspection - GlobeNewswire Inc.
Danaher stock rises 2.38 percent after the close - ad-hoc-news.de
Danaher Corp. stock outperforms competitors on strong trading day - MarketWatch
Danaher Schedules Third Quarter 2026 Earnings Conference Call - marketscreener.com
Danaher will webcast its next financial update Oct. 21 - Stock Titan
Danaher Corp. stock gains as valuation stays above fair value - AD HOC NEWS
Danaher Corp. stock gains 1.97 percent ahead of the open - AD HOC NEWS
Danaher stock ends the day 1.97 percent higher at the close - AD HOC NEWS
Danaher stock holds steady as reduced growth outlook tempers sentiment - AD HOC NEWS
Goldman Sachs Adjusts Price Target on Danaher to $250 From $210, Maintains Buy Rating - marketscreener.com
Danaher stock heads into the open after a modest loss - AD HOC NEWS
Danaher Corp. stock gains after UBS starts coverage with USD 250 target - AD HOC NEWS
Danaher stock gains after UBS starts coverage at USD 250 - AD HOC NEWS
Why Is Danaher (DHR) Drawing Fresh Attention? - Kalkine Media
Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better - Yahoo Finance
A new gene-editing tool is designed to reduce off-target edits - Stock Titan
Danaher (DHR) Could Be 8% Below Fair Value Following Its Dividend Reaffirmation - Yahoo Finance
Danaher Corp (DHR) Shares Surge 3.0% -- What GF Score of 80 Tells Investors - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Danaher Announces Quarterly Dividend - Yahoo Finance
Danaher Corp. stock holds near USD 200 as investors eye earnings and guidance - ad-hoc-news.de
3 Reasons DHR is Risky and 1 Stock to Buy Instead - Yahoo Finance
UBS assumes coverage on Danaher stock with buy rating, $250 target - Investing.com Nigeria
Thermo Fisher, Danaher Could Log Mid-Single-Digit Organic Revenue Growth in 2027, UBS Says - Yahoo Finance
Danaher Corp. stock gains support from UBS buy rating and July earnings beat - ad-hoc-news.de
Danaher stock heads into the open after a 0.87 percent slip - ad-hoc-news.de
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
0.46%
0.96%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):